ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Public Employees Retirement System of Ohio

Public Employees Retirement System of Ohio decreased its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 10.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,779 shares of the medical instruments supplier’s stock after selling 4,066 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.15% of ICU Medical worth $3,840,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Motco acquired a new position in ICU Medical in the 1st quarter worth $29,000. GAMMA Investing LLC raised its stake in shares of ICU Medical by 75.1% in the 1st quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 133 shares in the last quarter. EntryPoint Capital LLC raised its stake in shares of ICU Medical by 731.5% in the 1st quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 395 shares in the last quarter. CWM LLC raised its stake in shares of ICU Medical by 341.2% in the 4th quarter. CWM LLC now owns 578 shares of the medical instruments supplier’s stock valued at $58,000 after purchasing an additional 447 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its stake in shares of ICU Medical by 681.6% in the 4th quarter. Quadrant Capital Group LLC now owns 594 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 518 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insiders Place Their Bets

In other news, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $105.55, for a total value of $211,100.00. Following the completion of the sale, the insider now directly owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $105.55, for a total value of $211,100.00. Following the completion of the sale, the insider now directly owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Christian B. Voigtlander sold 12,539 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $103.95, for a total transaction of $1,303,429.05. The disclosure for this sale can be found here. In the last 90 days, insiders sold 14,839 shares of company stock worth $1,546,014. Insiders own 6.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Raymond James upgraded shares of ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 target price on the stock in a research note on Monday, June 17th. Needham & Company LLC initiated coverage on shares of ICU Medical in a research note on Friday, June 21st. They issued a “hold” rating on the stock. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $127.00.

ICU Medical Stock Performance

NASDAQ ICUI opened at $126.25 on Friday. ICU Medical, Inc. has a 52 week low of $78.28 and a 52 week high of $173.68. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.09 and a current ratio of 2.61. The company has a 50-day moving average price of $117.29 and a two-hundred day moving average price of $106.30.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 EPS for the quarter, topping the consensus estimate of $0.54 by $0.06. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The firm had revenue of $566.66 million during the quarter, compared to analysts’ expectations of $553.15 million. Sell-side analysts expect that ICU Medical, Inc. will post 3.5 EPS for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.